BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11835639)

  • 1. Patterns of in-stent restenosis after placement of NIR gold-coated stents in unselected patients.
    Danzi GB; Capuano C; Sesana M; Di Blasi A; Predolini S; Antoniucci D
    Catheter Cardiovasc Interv; 2002 Feb; 55(2):157-62. PubMed ID: 11835639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Taxus polymer-coated paclitaxel-eluting stents for treatment of in-stent restenosis in real world patients: results of clinical and angiographic follow-up at six months in a single-center registry.
    Lim VY; Buellesfeld L; Gerckens U; Mueller R; Schmidt T; Grube E
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):343-8. PubMed ID: 16897778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained increased risk of adverse cardiac events over 5 years after implantation of gold-coated coronary stents.
    Pache J; Dibra A; Schaut C; Schühlen H; Dirschinger J; Mehilli J; Kastrati A; Schömig A
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):690-5. PubMed ID: 17039510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: a multicenter prospective registry of 150 consecutive patients.
    Di Mario C; Morici N; Godino C; Goktekin O; Tamburino C; Barbagallo R; Antoniucci D; Grube E; Airoldi F; Zoccai GB; Colombo A; Sangiorgi GM
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):416-24. PubMed ID: 17191238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of cardiac events after implantation of sirolimus-eluting stents for treatment of in-stent restenosis.
    Le Feuvre C; Montalescot G; Rosey G; Collet JP; Beygui F; Choussat R; Gelft G; Monségu J; Ohanessian A; Spaulding C; Drobinski G; Metzger JP
    Int J Cardiol; 2006 May; 109(2):207-12. PubMed ID: 15993962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions.
    Coroleu SF; De Vita M; Burzotta F; Trani C; Porto I; Niccoli G; Leone AM; Tommasino A; Talarico GP; Schiavoni G; Crea F
    EuroIntervention; 2012 Oct; 8(6):701-7. PubMed ID: 23086788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of initial efficacy and long-term follow-up of heparin-coated Jostent with conventional NIR stent.
    Semiz E; Ermiş C; Yalçinkaya S; Sancaktar O; Değer N
    Jpn Heart J; 2003 Nov; 44(6):889-98. PubMed ID: 14711184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with a new biocompatible phosphorylcholine-coated coronary stent.
    Zheng H; Barragan P; Corcos T; Siméoni JB; Favereau X; Roquebert PO; Guérin Y; Sainsous J
    J Invasive Cardiol; 1999 Oct; 11(10):608-14. PubMed ID: 10745442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System.
    Cutlip DE; Garratt KN; Novack V; Barakat M; Meraj P; Maillard L; Erglis A; Jauhar R; Popma JJ; Stoler R; Silber S;
    JACC Cardiovasc Interv; 2017 Jan; 10(2):160-167. PubMed ID: 28104210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus-eluting stent implantation for bare-metal in-stent restenosis: is there any evidence for a late catch-up phenomenon?
    Sheiban I; Chiribiri A; Galli S; Biondi-Zoccai G; Montorsi P; Beninati S; Fabbiocchi F; Moretti C; Omedè P; Trabattoni D; Lotrionte M; Trevi GP; Bartorelli AL
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):783-8. PubMed ID: 18607241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications and immediate and long-term results of a novel pericardium covered stent graft: Consecutive 5 year single center experience.
    Secco GG; Serdoz R; Kilic ID; Caiazzo G; Mattesini A; Parisi R; De Luca G; Pistis G; Marino PN; Di Mario C
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):712-9. PubMed ID: 26541909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of drug-eluting stents for the treatment of in-stent restenosis in routine clinical practice.
    Belardi JA; Cura F; Albertal M; Padilla L; Solioz G; Balino PP; Pascua JA; Fava C; Berrocal D; Mendiz O; Grinfeld L
    Coron Artery Dis; 2005 Aug; 16(5):327-30. PubMed ID: 16000892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
    Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent fracture associated with drug-eluting stents: clinical characteristics and implications.
    Lee MS; Jurewitz D; Aragon J; Forrester J; Makkar RR; Kar S
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):387-94. PubMed ID: 17195203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NUGGET study: NIR ultra gold-gilded equivalency trial.
    Reifart N; Morice MC; Silber S; Benit E; Hauptmann KE; de Sousa E; Webb J; Kaul U; Chan C; Thuesen L; Guagliumi G; Cobaugh M; Dawkins K;
    Catheter Cardiovasc Interv; 2004 May; 62(1):18-25. PubMed ID: 15103594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
    Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
    Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
    Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
    EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.
    Aoki J; Nakazawa G; Tanabe K; Hoye A; Yamamoto H; Nakayama T; Onuma Y; Higashikuni Y; Otsuki S; Yagishita A; Yachi S; Nakajima H; Hara K
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):380-6. PubMed ID: 17195199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.